Altimmune to participate at leerink partners therapeutics forum

Gaithersburg, md., july 02, 2024 (globe newswire) -- altimmune, inc. (nasdaq: alt), a clinical-stage biopharmaceutical company, today announced that members of the company's management team will be hosting one-on-one meetings with institutional investors at the leerink partners therapeutics forum: i&i and metabolism, being held on july 9 and 10, 2024 in boston, ma. the event will feature analyst-hosted panel discussions with leading physicians in a range of autoimmune and metabolic indications, as well as meetings between participating companies and investors.
ALT Ratings Summary
ALT Quant Ranking